Diagnostic procedures

• FC 18-01 • Effectiveness of HPV testing in ASC-US to predict HSIL See abstract > S. Silvia De Sanjose • FC 18-02 • Colposcopic and histopathologic evaluation in women aged 56-64 with HPV-persistence 1 and 3 years, respectively, from the organized primary HPV screening in Sweden. See abstract > K. K. ELFGREN • FC 18-03 • Evidence for clinical application of extended HPV genotyping in persistence tracking and test-of-cure: a systematic review See abstract > Y. Y. SAMMY • FC 18-04 • Risk of cervical cancer after atypical glandular cells found at screening in the Netherlands See abstract > C. C. AITKEN • FC 18-05 • Risk factor analysis of residual HSIL after LEEP: a clinical study of 1511 LEEP cases at Ob&Gy hospital of Fudan University See abstract > L. L. CHEN • FC 18-06 • HPV cell-free DNA in plasma as an useful marker for monitoring relapse of cervical cancer See abstract > J. J.E. LEVI • FC 18-07 • Prevalence and risk factors for mutizonal neoplasia in a cohart of high-risk women See abstract > M. M. GODFREY • FC 18-08 • Is p16/ki67 dual-stained cytology essential at a colposcopy department? See abstract > F. F. SANTOS • FC 18-09 • Clinical-pathological variables associated with cervical conizations specimens without high-grade intraepithelial lesion: a study of 221 cases. See abstract > F. F.J. QUEIPO GUTIERREZ • FC 18-10 • Comparison of pain control by Lidocaine spray and paracervical nerve block during loop electrosurgical procedure: a randomized control trial See abstract > N. N. LIMWATANAPAN • FC 18-11 • Crosswalking European guidelines on the management of vaginal discharge and the management of STI See abstract > S. S. KODSI • FC 18-12 • Rapid Evaporative Ionization Mass Spectrometry (REIMS) iknife and its cervical application in the treatment of cervical abnormalities See abstract > M. M. TZAFETAS